Routine use of thromboprophylaxis may be over treatment and definitely increases healthcare costs. While prophylaxis may reduce the number of thrombi formed the exact number and clinical significance of these is unknown. This study seeks to answer the question of whether or not DVT prophylaxis with low-molecular-weight heparin (LMWH) following ORIF of ankle fractures is warranted.
Age
18–85
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
At least 18 years old
Surgical ankle fracture able to be definitively treated with one operation
